Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ICPA is like Coney Island "Cyclone"
Haven't been on that RollerCoaster since High School days.....but ICPA sure is bringing back good memories. What a Great ride....please don't stop.
DayBull
You can't hold a Good Man down too long.
Back to the .0015 soon......
DayBull
LEAP FROG TODAY
Been 5 Days in the "Red Pond"......Ready to take that huge leap....Can't hold a good Frog down.
DayBull
TAG OF THE DAY
Ready to blow....chart looks amazing. Loading more on the shelf and tagging it "Price Reduced".
DayBull
Hope ICPA DOESN'T GET BANNED
Thank God for Freedom of Speech and the Free Stock Trade Market. Let's Keep America and ICAP Great.
DayBull
Investor News
Fron Lazaro Garcia, CEO
We would like to take this opportunity to invite you to review this website in an effort to learn valuable information about our Company. Below you will find responses to frequently asked questions (FAQs) that we have collected from other investors and employees along with our responses to those FAQs. We will continue to respond to investor questions in an effort to keep all of investors informed about our Company. In addition, please take some time to review our information posted on our quotation page located on the OTC Markets Group website at www.otcmarkets.com. There you will find our latest press release regarding corporate events and actions that are happening with our Company as well as financial reports we file with the OTC Markets Group. We value our investors and hope you will join our community as we begin to build what we believe will become a world class organization that provides high-quality home health care services throughout each new community in which we will establish an agency location.
Contact Info: Phone: 305-423-7119
DayBull
BUY recommendation and a 12-month price target of $5.95 per share
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 23, 2012
SEFE, INC.
ITEM 7.01 REGULATION FD DISCLOSURE
On April 23, 2012, a press release was issued by Grass Roots Research & Distribution, an independent micro-cap research firm (“GRRD”), stating that GRRD has initiated coverage of the Registrant’s common stock (Over-the-Counter Bulletin Board symbol: SEFE.ob). GRRD performed an in-depth analysis, with participation by the Registrant, including 5-year financial and valuation projections of SEFE (the “Report”). The Report may be obtained directly from GRRD. The full text of the press release is attached as Exhibit 99.1 to this report and is incorporated by reference into this Item 7.01.
SAN RAFAEL, CA--(Marketwire -04/23/12)- Grass Roots Research & Distribution Inc. (GRRD), Wall Street's leading independent micro-cap research firm, has announced that it has initiated coverage on SEFE (OTC.BB: SEFE.OB - News ) with a BUY recommendation and a 12-month price target of $5.95 per share. GRRD provides an in-depth analysis, including 5-year financial and valuation projections, on SEFE's business and its significant growth drivers. A copy of the report is available for download at http://www.grassrootsrd.com .
An excerpt from the GRRD report states, "With SEFE's patented technology, a strong market opportunity for alternative and clean technology energy solutions should emerge providing considerable upside for SEFE's stock. We are initiating coverage with a BUY rating."
DayBull
$400M Buyback of Shares
Eat Crow Cramer: Buy, Buy, Buy, back to $16.
Allscripts Announces Increase To Stock Repurchase Program And Names Board Chairman --Expanded Repurchase Program Adds $200 Million to $148 Million Remaining on Repurchase Program Announced in May 2011 --Elects Dennis Chookaszian Chairman of the Board CHICAGO, April 30, 2012 /PRNewswire via COMTEX/ -- Allscripts Healthcare Solutions, Inc. (allscripts - nasdaq:MDRX) today announced that its Board of Directors has authorized management to repurchase an additional $200 million of Allscripts common stock, bringing the total repurchase authorization to $400 million. Since May 5, 2011, the Company has repurchased approximately $52 million of Allscripts common stock under its previously approved $200 million share repurchase program. Repurchases may be made pursuant to Rule 10b5-1 or 10b-18 of the Securities Exchange Act of 1934, as amended. Any share repurchases may be made through open market transactions, block trades, privately negotiated transactions (including accelerated share repurchase transactions) or other means. Any repurchase activity will depend on factors such as the Company's working capital needs, cash requirements for investments, debt repayment obligations, stock price, and economic and market conditions. There is no guarantee as to the exact number of shares or value thereof that will be repurchased under the stock repurchase program. The stock repurchase program may be accelerated, suspended, delayed or discontinued at any time. Allscripts also announced today that its Board of Directors has elected Dennis Chookaszian Chairman. Mr. Chookaszian, who has been a director since September 2010, has a wide range of experience as a chief executive officer and public company board member. From 1999 until 2001, Mr. Chookaszian served as Chairman and Chief Executive Officer of mPower, Inc., a financial advice provider focused on the on-line management of 401(k) plans. Mr. Chookaszian served as Chairman and Chief Executive Officer of CNA Insurance Companies from 1992 to 1999 and as Chairman of the Executive Committee from 1999 to 2002. During his 27-year career with CNA, Mr. Chookaszian held several management positions, including President and Chief Operating Officer from 1990 to 1992 and Chief Financial Officer from 1975 to 1990. Mr. Chookaszian currently serves as a director of CME Group, Inc., Career Education Corporation and Internet Patent Corp. Mr. Chookaszian also served as Chairman of the Financial Accounting Standards Advisory Council (FASAC), the advisory council to the Financial Accounting Standards Board (FASB), from January 2007 to December 2011. About Allscripts Allscripts (MDRX) delivers the insights that healthcare providers require to generate world-class outcomes. The company's Electronic Health Record, practice management and other clinical, revenue cycle, connectivity and information solutions create a Connected Community of Health(TM) for physicians, hospitals and post-acute organizations. To learn more about Allscripts, please visit http://www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the federal securities laws. Statements regarding future events or developments, our future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements with the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on our results of operations or financial condition. Such risks, uncertainties and other factors include, among other things: the possibility that the expected synergies, efficiencies and cost savings of the merger with Eclipsys Corporation ("Eclipsys") will not be realized, or will not be realized within the expected time period; potential difficulties or delays in achieving platform and product integration and the connection and movement of data among hospitals, physicians, patients and others; the risk that the Allscripts and Eclipsys businesses will not be integrated successfully; competition within the industries in which we operate, including the risk that existing clients will switch to products of competitors; failure to achieve certification under the Health Information Technology for Economic and Clinical Health Act could result in increased development costs, a breach of some customer obligations and could put us at a competitive disadvantage in the marketplace; the volume and timing of systems sales and installations, the length of sales cycles and the installation process and the possibility that our products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; undetected errors or similar problems in our software products or other product quality issues; the outcome of any legal proceeding that has been or may be instituted against us; compliance with existing laws, regulations and industry initiatives and future changes in laws or regulations in the healthcare industry, including possible regulation of our software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; the implementation and speed of acceptance of the electronic record provisions of the American Recovery and Reinvestment Act of 2009; maintaining our intellectual property rights and litigation involving intellectual property rights; risks related to third-party suppliers and our ability to obtain, use or successfully integrate third-party licensed technology; and breach of our security by third parties. See our Annual Report on Form 10-K for 2011 and other public filings with the SEC for a further discussion of these and other risks and uncertainties applicable to our business. The statements herein speak only as of their date and we undertake no duty to update any forward-looking statement whether as a result of new information, future events or changes in expectations.
DayBull
PatientCore 1 Is Launched......Great News!
Home Health International, Inc. Announces Strategic Priority for 2012 and Beyond PatientCore 1 Is Launched VERO BEACH, FL, Apr 30, 2012 (MARKETWIRE via COMTEX) -- Home Health International, Inc. (pinksheets:HHII) is pleased to announce their Patient Centric Priority initiative for 2012. The Company's future success is aligned with the patient at its core. The team of medical professionals is passionate to gain specific insights for the needs of their patients because it's these learnings that will ensure the growth and success of the business. The CEO states, "For 2012 and beyond Home Health International will formally incorporate our recognized patient centric passion to drive our business. The newly launched program is called PatientCore 1. In this new way of doing business we listen and incorporate patient learnings to create real solutions. PatientCore 1 is about the entire process, to service our patients correctly and effectively through a wide arrange of home health services that bring comfort, relaxation, and unrelenting trust in how we conduct ourselves." To learn more about Home Health International, please visit http://www.homehealthintl.com. About Home Health International Inc. Home Health International Inc. was incorporated in the State of Nevada on September 13, 2006. The Company was formerly known as Micro Mammoth Solutions, Inc. and operated as such until January 25, 2010. On January 26, 2010, the Board of Directors of the Company approved a Stock Purchase Agreement between the Company and all of the shareholders of Atlas Capital Partners, LLC. Following the acquisition of Atlas Capital Partners the shareholders approved an amendment to the Company's Articles of Incorporation changing the Company's name from Micro Mammoth Solutions, Inc. to Atlas Capital Holdings, Inc. The Company received shareholder and board approval to amend its Articles of Incorporation to change its name to Home Health International Inc. This change was approved by FINRA and became effective on March 26, 2012.
DayBull
The Pick of The Day is: SNPK
Hello everyone,
It seems that many people got scared last week as SNPK was dipping, those investors got out of their positions which made SNPK drop significantly, but this turned out to be a perfect opportunity for SNPK to prove to us that it is truly a strong fighter because, SNPK is on the rise once again!
We like to think of SNPK as a Hollywood star! It just keeps impressing us with new campaigns, media coverage and reports with very high targets! Most importantly, no matter how low it almost goes, it always seems to bounce right back up; there is no slowing this pick down!
When we first mentioned SNPK in our newsletter we did something that was completely unprecedented, we made a promise! We promised you that we firmly believed in SNPK and those who bought it saw gains of over 400%. All our picks in the last year and a half have done really well for our subscribers, so think about it; why would we still be covering SNPK if we did not firmly believe that it could still have a long way to go!
The main reason we think of SNPK as a Hollywood star is because every time it announces good news, its price shoots up, exactly like a movie star or a singer who makes a hit and makes millions. Who can forget when SNPK announced its affiliation with Paul Silas and Walgreens within the same week and doubled in price a week later? Who can forget when SNPK started running television adds and selling Clotamin in Europe and hit 2$ thereafter, multiplying your investments massively.
Well, here is the next big news that we believe could give SNPK the boost it needs to run higher than it has ever been:
-SNPK has signed an advertising agreement with CBS radio. New York City based WFAN 660AM is considered a pioneer of the sports radio format and has been home to some of the biggest celebrity names in radio. In total, 120 Live Read and 45 recorded Clotamin advertisements are expected to be aired over the 3 week duration of the contract period in May
-SNPK announced just this week that Burt Reynolds, a golden globe winner and Oscar nominee, will actually be putting his face on their ads. Remember, celebrity endorsements are one of the proven ways to multiply the value of a company. In additions to Paul Silas, who is still an official spokesperson for Clotamin, and many sports teams who are being used to advertise the product, Burt Reynolds should be able to give SNPK that huge push towards the stars.
-SNPK struck deals to place Clotamin in close to 500 Wallgreens locations all over the nation and continues working on international expansion plans.
-SNPK has a venture with AACSA that could get Clotmin into up to 11,200 retail locations in the country!
In short, we believe that the only thing last week's drop has given us is a second chance to those of you who wished they had gotten on board when this was trading at low prices. Do you really believe that SNPK will stay at less than a dollar for long, this may be your final chance!
Intelligent investors learn from their mistakes and do better next time, when analysts initially told us that SNPK was bound to rise it did, now here it is again, back to 0.70$; what's your move?
Happy Trading!
Your AwesomePennyStocks Editor.
You're Welcome
Here's the real DD:
Associated Home Health is incorporated with PA, not FL.
ASSOCIATED HOME HEALTH, INC. Current Name
Business Corporation - Domestic - Information
Entity Number: 3154144
Status: Active
Entity Creation Date: 7/24/2003
State of Business.: PA
Registered Office Address: 604 Oak Street
Irwin PA 15642
Westmoreland
Mailing Address: No Address
Officers
Name: SUDHA DOSHI
Title: President
Address: 2010 NE 45TH ST
FT LAUDERDAL FL 33308
https://www.corporations.state.pa.us/corp/soskb/Corp.asp?2043069
One can see it matches the address on the website
Headquarters
Address: 2010 NE 45th Street
Fort Lauderdale, FL 33308-5122
Phone: 954-616-6000
Hours: 9am to 5pm (EST)
contactus@associatedhh.com
http://www.associatedhomehealth.com/index.php
DayBull
WOW on the FAN 660 AM Radio
Big NY Media Sports Radio with Joe and Boomer. This will kept SNKP running up, and up to that $9 prediction. I'm in with more shares on Monday.
RATIING: Strong, Strong Buy
DayBull
This company is for real.
About Sunpeaks Ventures, Inc.
Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market. HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.
For additional information, please visit www.sunpeaksventures.com.
Contact: Financial Insights 888-248-8491 or info@sunpeaksventures.com
DayBull
Great News
Don't miss the run-up today!
DayBull
Little Bleeding Yesterday
Wound healing well.....Company on the move dispite unwarranted bashing. See news below:
Home Health International, Inc. to Expand Management Team VERO BEACH, FL, Apr 27, 2012 (MARKETWIRE via COMTEX) -- Home Health International, Inc. (pinksheets:HHII) announced today that it is in the process of recruiting a Chief Operating Officer and VP of Marketing to expand its management team. The Company is currently sourcing qualified candidates with extensive home health care expertise from executive management search firms and online recruiting platforms. The Company plans to have these key hires onboard within the next 60 days. To learn more about Home Health International, please visit http://www.homehealthintl.com. About Home Health International, Inc. Home Health International, Inc. was incorporated in the State of Nevada on September 13, 2006. The Company was formerly known as Micro Mammoth Solutions, Inc. and operated as such until January 25, 2010. On January 26, 2010, the Board of Directors of the Company approved a Stock Purchase Agreement between the Company and all of the shareholders of Atlas Capital Partners, LLC. Following the acquisition of Atlas Capital Partners the shareholders approved an amendment to the Company's Articles of Incorporation changing the Company's name from Micro Mammoth Solutions, Inc. to Atlas Capital Holdings, Inc. The Company received shareholder and board approval to amend its Articles of Incorporation to change its name to Home Health International Inc. This change was approved by FINRA and became effective on March 26, 2012.
DayBull
Drinks on me.....
I'll settle my tab tomorrow....when she blows to the sky.
DayBull
Sat on my Bottom today
Cause I ate like a fat CAT.....and I know there's pie in the Sky tomorrow.
RATING: Extra Strong, Strong Buy
DayBull
Looking a Year Ahead
Bollinger Report screened and selected Sefe Incorporated for its current position within the industry. SEFE, Inc. (SEFE), formerly Midnight Candle Company, is a development-stage company. The Company focused to develop and bring to market a renewable source of energy, which occurs in the atmosphere. It uses its methodologies and inventions to capture and convert this naturally occurring atmospheric static electric energy to usable energy. A copy of this report featuring Sefe Incorporated (SEFE) is available at: http://www.BollingerReport.com/index.php?sm1=SEFE.
RATING: Extra Strong Buy
.07 IMO
In since .0027. Took some profits on the way up - and bought more on the dips.
Don't miss your flight here.....get in before she shoots up to 7 cents.
RATING: Strong Buy
DayBull
Too Much Hoopla
This baby will gain $100%+ on Friday.
Get your pennies ready and go with me to the bank.
DayBull
RATING: Buy, Buy, Buy,
Solar Energy is the Future
NRG Energy, MidAmerican Solar and First Solar Celebrate 100 MW Milestone for 290 MW Agua Caliente Solar Project
PRINCETON, N.J. & DES MOINES, Iowa & TEMPE, Ariz., Apr 25, 2012 (BUSINESS WIRE) -- Representatives from NRG Energy, Inc. (NRG, Trade ), MidAmerican Solar and First Solar, Inc. (FSLR, Trade ) gathered with federal and local officials today at the 290 megawatt (AC) Agua Caliente solar project in Yuma County, Ariz., to celebrate the project's first 100 megawatts (MW) being delivered to the grid, making it North America's largest photovoltaic (PV) power plant in operation.
Once completed in 2014, Agua Caliente will be one of the world's largest PV power plants, supplying enough clean, renewable solar energy to power more than 225,000 homes. The project's construction phase is creating an average of 400 jobs, with over 80% of the workforce coming from Arizona.
"Getting to this milestone of our first 100 megawatts at Agua Caliente illustrates the success of public-private partnerships to stimulate the construction of these large-scale solar projects, creating hundreds of construction jobs and providing clean, renewable power to thousands of homes," said Tom Doyle, president of NRG Solar. "Large-scale projects like this also help drive down the price of solar, which will make it even more cost-competitive with conventional electricity generation in the near future."
First Solar is a leading global provider of comprehensive photovoltaic (PV) solar systems which use its advanced thin-film modules. The company's integrated power plant solutions deliver an economically attractive alternative to fossil-fuel electricity generation today. From raw material sourcing through end-of-life module collection and recycling, First Solar's renewable energy systems protect and enhance the environment. For more information about First Solar, please visit www.firstsolar.com .
DayBull
HHII....the next 10 bagger.
Spoke to Transfer Agent-Madison Stock in Bklyn, NY and confirmed stock shares figures.
Lazaro Garcia as CEO is making all the right moves to get uplisted to QB on the OTCBB.
Don't miss the boat.....
DayBull
I Think New Attorneys are fake too.
VERO BEACH, FL--(Marketwire -04/24/12)- Home Health International, Inc. (HHII.PK - News) is pleased to announce that it has engaged the law firm of Akerman Senterfitt to assist the Company with due diligence and contract preparation related to acquisition transactions that are presently under consideration by the Company.
Akerman is ranked among the top 100 law firms in the United States by The National Law Journal NLJ 250 (2012) in number of lawyers and is the leading Florida firm. With 500 lawyers and government affairs professionals, Akerman serves clients throughout the United States and overseas from Florida, New York, Washington, D.C., California, Virginia, Colorado, Nevada, Utah and Texas. More information can be found at http://www.akerman.com/
To learn more about Home Health International, please visit http://www.homehealthintl.com.
About Home Health International Inc.
Daybull
Ditto.......
DayBull
Now's the time to buy. "Seeking Alpha" Rates it a BUY with a Price Target of $52.
DayBull
ZNXT - IS A GOLD MINE! Still waiting for dividends and conversion of Preferred Shares. Just bought more @ .05 cents - a steal. Should blow past .10 cents......BUY, BUY, BUY.
DAYBULL